Theolytics expands Series A financing and welcomes M Ventures as a new investor

Theolytics is harnessing viruses to combat cancer: transforming patients' lives; through world leading science; with a great team OXFORD, England, July 8, 2021 -- (Healthcare Sales & Marketing Network) -- M Ventures – the strategic venture capital arm ... Biopharmaceuticals, Venture Capital Theolytics, oncolytic virus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news